OPRX: OptimizeRx Corporation Stock

by  •  • Comments Off on OPRX: OptimizeRx Corporation Stock

SIC 7389 – Business Services, Not Elsewhere Classified

Valuation
Market Cap ($M) 161.61
Enterprise Value ($M) 181.04
Book Value ($M) 117.00
Book Value / Share 6.33
Price / Book 1.38
NCAV ($M) -0.20
NCAV / Share -0.01
Price / NCAV -812.09

Profitability (mra)
Return on Invested Capital (ROIC) -0.13
Return on Assets (ROA) -0.11
Return on Equity (ROE) -0.16

Liquidity (mrq)
Quick Ratio 2.89
Current Ratio 2.89

Balance Sheet (mrq) ($M)
Current Assets 53.97
Assets 171.17
Liabilities 54.17
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 92.13
Operating Income -6.22
Net Income -20.11
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 4.89
Cash from Investing -0.45
Cash from Financing -4.91

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
9 days ago 13D/A Whetstone Capital Advisors, LLC 8.20 0.00
02-13 13G/A Samjo Management, LLC 0.00 -100.00
01-28 13G Royce & Associates Lp 5.81
01-08 13G/A First Light Asset Management, LLC 0.00 -100.00
12-06 13G/A AWM Investment Company, Inc. 4.80 -18.04
11-14 13G/A Divisadero Street Capital Management, LP 0.02 -99.67

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2024 ☐ Transition Report pursuant t
2024-08-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2024 ☐ Transition Report pursuant to 13
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2024 ☐ Transition Report pursuant to 13

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-29 35,170 112,405 31.29
2025-04-28 42,237 122,346 34.52
2025-04-25 26,797 128,754 20.81
2025-04-24 13,484 81,671 16.51

(click for more detail)

Similar Companies
NUTX – Nutex Health Inc. OCG – Oriental Culture Holding LTD
OLB – The OLB Group, Inc. PAYS – Paysign, Inc.
PRTH – Priority Technology Holdings, Inc.


Financial data and stock pages provided by
Fintel.io